caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1891759650

Emily LiuM.D.

EndocrinologyLawrence, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Emily Liu's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 57 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
270857
STEWARD HOLY FAMILY HOSPITAL, INC.109282
Catherine Lehan
Nurse Practitioner · Derry, NH
58131
BILAZARIAN, SETH40109
German Iosif
Internal Medicine · Haverhill, MA
39158
NEURO REHAB ASSOCIATES, INC33147
Sangeeta Nadkarni
Internal Medicine · Lawrence, MA
31105
Kevin Berry
Cardiology · Methuen, MA
3145
THOMPSON, JANE3086
Emily Dulude
Nephrology · Haverhill, MA
2996
Stewart Hou
Diagnostic Radiology · Lawrence, MA
2544
Lawrence Casha
Diagnostic Radiology · Lawrence, MA
2534
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,114
Unique beneficiaries
—
Total services
5,088
Distinct HCPCS
15
Medicare payment
$190K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 341 Endocrinology providers in MA — top quintile (cohort median 496).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
7,486
Beneficiaries
—
Total drug cost
$4.0M
Distinct drugs
52
Brand share
69.1%
Top prescribed drugs
Semaglutide803 claims
Levothyroxine Sodium798 claims
Empagliflozin563 claims
Dulaglutide552 claims
Metformin Hcl456 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$848
Payment records
9
By payment type
Travel and Lodging$655
Food and Beverage$193